Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes

Biochemical and Biophysical Research Communications
R KoderaH Makino

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors are incretin-based drugs in patients with type 2 diabetes. In our previous study, we showed that glucagon-like peptide-1 (GLP-1) receptor agonist has reno-protective effects through anti-inflammatory action. The mechanism of action of DPP-4 inhibitor is different from that of GLP-1 receptor agonists. It is not obvious whether DPP-4 inhibitor prevents the exacerbation of diabetic nephropathy through anti-inflammatory effects besides lowering blood glucose or not. The purpose of this study is to clarify the reno-protective effects of DPP-4 inhibitor through anti-inflammatory actions in the early diabetic nephropathy. Five-week-old male Sprague-Dawley (SD) rats were divided into three groups; non-diabetes, diabetes and diabetes treated with DPP-4 inhibitor (PKF275-055; 3 mg/kg/day). PKF275-055 was administered orally for 8 weeks. PKF275-055 increased the serum active GLP-1 concentration and the production of urinary cyclic AMP. PKF275-055 decreased urinary albumin excretion and ameliorated histological change of diabetic nephropathy. Macrophage infiltration was inhibited, and inflammatory molecules were down-regulated by PKF275-055 in the glomeruli. In addition, nuclear factor-κB (NF-κB) a...Continue Reading

References

Nov 16, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E RitzS Halimi
Sep 24, 2005·Journal of the American Society of Nephrology : JASN·Kosuke YozaiHirofumi Makino
Jan 20, 2009·Biochemical and Biophysical Research Communications·Kunio HirataTakashi Uzu
Aug 24, 2010·Vascular Health and Risk Management·James E Foley, Jens Jordan
Jan 6, 2011·Endocrine Journal·Sachiko Hattori
May 4, 2011·Nature Reviews. Nephrology·Juan F Navarro-GonzálezJavier García-Pérez
May 20, 2011·American Journal of Physiology. Renal Physiology·Renato O CrajoinasAdriana C C Girardi
Oct 26, 2011·The Journal of Pharmacology and Experimental Therapeutics·Wei Jing LiuTae Sun Park
Oct 19, 2012·Clinical Science·Jun Wada, Hirofumi Makino

❮ Previous
Next ❯

Citations

May 6, 2014·Reviews in Endocrine & Metabolic Disorders·Jeppe Skov
Jan 24, 2016·Biochemical and Biophysical Research Communications·Yuki TanakaHiroshi Maegawa
Jan 28, 2016·Journal of Diabetes Investigation·Ryo Kodera, Kenichi Shikata
Jan 30, 2016·Journal of Diabetes Research·Zihan Zheng, Feng Zheng
Apr 26, 2016·Mediators of Inflammation·Young-Sun Lee, Hee-Sook Jun
Sep 18, 2015·Frontiers in Immunology·Usha Panchapakesan, Carol Pollock
Feb 3, 2015·Transplantation Reviews·Johannes WerzowaManfred Hecking
Sep 17, 2015·Nephrology·Muralikrishna Gangadharan KomalaUsha Panchapakesan
May 13, 2014·Mediators of Inflammation·Catarina MarquesRosa Fernandes
Aug 3, 2016·International Journal of Molecular Sciences·Daiji KawanamiKazunori Utsunomiya
Apr 20, 2017·Journal of Molecular Endocrinology·Ahmed A Hasan, Berthold Hocher
Nov 27, 2018·The Journal of Endocrinology·Eun Soo LeeChoon Hee Chung
Sep 5, 2017·Nature Reviews. Nephrology·Marcel H A MuskietDaniël H van Raalte
Nov 22, 2014·Current Opinion in Nephrology and Hypertension·Yuichi MakinoMasakazu Haneda
Feb 7, 2015·American Journal of Physiology. Renal Physiology·Yoshiki HigashijimaMasaomi Nangaku
Jan 27, 2017·American Journal of Physiology. Renal Physiology·Ravi Nistala, Virginia Savin
Oct 18, 2019·Current Drug Delivery·Di ZhangYueze Liu
Apr 27, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Aly M AbdelrahmanBadreldin H Ali
Sep 29, 2017·Endocrinology and Metabolism·Yu Mi Kang, Chang Hee Jung
Jul 15, 2020·Diabetes/metabolism Research and Reviews·Ingeborg T Hoffmann-PetersenJakob A Østergaard
Jul 15, 2017·The Korean Journal of Internal Medicine·Mi-Kyung Kim
Feb 19, 2019·Oxidative Medicine and Cellular Longevity·Donato CappettaKonrad Urbanek
Aug 18, 2018·Current Diabetes Reports·Mustafa TosurSarah K Lyons
Nov 8, 2016·Current Opinion in Nephrology and Hypertension·Yuta TakagakiKeizo Kanasaki
Nov 22, 2020·Nature Reviews. Nephrology·Radica Z AlicicKatherine R Tuttle
Dec 31, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Izabela Tuleta, Nikolaos G Frangogiannis
Jul 30, 2019·International Immunopharmacology·Yunjuan Zhao
Feb 9, 2021·Journal of Diabetes and Metabolic Disorders·Fariba AghahoseiniReza Badalzadeh
Feb 11, 2021·Antioxidants·Daiji KawanamiMakito Tanabe
Jun 20, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ramona NicoteraGiuseppe Coppolino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.